Mangoceuticals (MGRX) Revenue & Revenue Breakdown
Mangoceuticals Revenue Highlights
Latest Revenue (Y)
$473.26K
Latest Revenue (Q)
$109.31K
Mangoceuticals Revenue by Period
Mangoceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $473.26K | -35.30% |
| 2023-12-31 | $731.49K | 8083.16% |
| 2022-12-31 | $8.94K | 100.00% |
| 2021-12-31 | - | - |
Mangoceuticals generated $473.26K in revenue during NA 2024, up -35.30% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Mangoceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $109.31K | 3.86% |
| 2024-12-31 | $105.25K | -21.09% |
| 2024-09-30 | $133.37K | -18.26% |
| 2024-06-30 | $163.16K | -23.79% |
| 2024-03-31 | $214.09K | -12.39% |
| 2023-12-31 | $244.37K | -0.32% |
| 2023-09-30 | $245.16K | 73.58% |
| 2023-06-30 | $141.24K | 40.22% |
| 2023-03-31 | $100.72K | 1026.77% |
| 2022-12-31 | $8.94K | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | - |
Mangoceuticals generated $109.31K in revenue during Q1 2025, up 3.86% compared to the previous quarter, and up 44.73% compared to the same period a year ago.
Mangoceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PIII | P3 Health Partners | $1.50B | $373.23M |
| CASI | CASI Pharmaceuticals | $33.88M | $3.41M |
| CLGN | CollPlant Bio | $10.96M | $98.00K |
| NXGL | NEXGEL | $8.69M | $2.88M |
| MGRX | Mangoceuticals | $473.26K | $109.31K |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| ENTO | Entero Therapeutics | - | - |
| ENLV | Enlivex Therapeutics | - | - |
| LPTX | Leap Therapeutics | - | - |
| PASG | Passage Bio | - | - |